Osman MERMİ, Murad ATMACA, Sema BAYKARA, Ömer ÖZER

Haloperidol- Induced Cardiopulmonary Arrest: A Case Report

Haloperidol, acil servislerde ve psikiyatri servislerinde yaygın olarak kullanılan bir antipsikotiktir. Bu ilacın kullanımı sırasında dikkat edilmediği takdirde ciddi olabilen komplikasyonlara rastlanabilmektedir. Bu komplikasyonlar arasında kardiyak kökenli olanlar özellikle önem taşımaktadırlar. Literatürde olgu sunumları şeklinde, haloperidol kullanımı ile birlikte sık olmayarak yaşamı tehdit edebilen aritmiler bildirilmiştir. Yazımızda haloperidol kullanırken kardiyopulmoner arrest geçiren bir olguyu sunmayı amaç- ladık.

Haloperidol kullanımına bağlı kardiyopulmoner arrest: Bir vaka sunumu

Haloperidol is an antipsychotic which is widely used in emergency and psychiatry units. Sometimes, it is encountered some serious complications associated with haloperidol use, particularly haloperidol induced cardiac ones. In literature, life-threatening arrhythmias have been reported as case reports. Here, we report a case who had haloperidol-induced cardiopulmonary arrest.

PDF

___

1. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150:1115-21.
2. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull. 1996;22:413-30.
3. Buckley NA, Sanders N. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf. 2000;23:215-28.
4. Passman R, Kadish A. Polymorphic ventricular tachycardia, long QT syndrome, and torsades de pointes. Med Clin North Am. 2001;85:321-41.
5. Chong SA, Mythily, Mahendran R. Cardiac effects of psychotropic drugs. Ann Acad Med. 2001;30:625-31.
6. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355:1048-52.
7. Uzbay T (çeviri editörü), Stahl'ın Temel Psikofarmakolojisi İstanbul: İstanbul Medikal Yayıncılık, 2012.
8. Ravin DS, Levenson JW. Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother. 1997;31:867-70.
9. Fayer SA. Torsade de pointes ventricular tachyarrhythmia associated with haloperidol [letter]. J Clin Psychopharmacol. 1986;6:375-6.
10. Hunt N, Stern TA. The association between intravenous haloperidol and torsades de pointes: three cases and a literature review. Psychosomatics. 1995;36:541-9.
11. Huyse F, Van Schijndel RS. Haloperidol and cardiac arrest. Lancet. 1988;3:568-9.
12. Shilpa J, Hammad R, Pratt JD, Anita S. Cardiopulmonary arrest secondary to haloperidol The American Journal of Emergency Medicine. 2000;18:839.
13. Czekalla J, Beasley CM Jr, Dellva MA, Berg PH, Grundy S. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. J Clin Psychiatry. 2001;62:191-8.
14. Moss AJ: Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23- 5.
15. Simonson E, Cady LD, Woodbury M. The normal QT interval. Am Heart J. 1962; 63:747-751.
16. Morganroth J, Brozovich FV, McDonald JT, Jacobs RA. Variability of the QT measurement in healty men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. Am J Cardiol. 1991;67:774-6.
17. Garson AJ. How to measure the QT interval: what is normal? Am J Cardiol. 1993;72:14-6.
18. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991;83:1888-94.
19. Singh BN. When is QT prolongation antiarrhythmic and when is it proarrhythmic? Am J Cardiol. 1989;63:867-9.
20. Barnes TRE, Mcphillips MA. Critical analysis and comparison of the side effects and safety profiles of the new antipsychotics. Br J Psychiatry. 1999;174:4-43.
21. Warner JP, Barnes TRE, Henry JA. Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatrica Scandinavica. 1996;93:311-3.
22. İlhan A, Özcan M E, Tuncer C, Kali S, Boztepe A V, Pekdemir H. Antipsikotik kullanımının ventriküler repolarizasyon parametreleri üzerine etkileri. Klinik Psikofarmakoloji Bülteni. 1999;9:112-7.
23. Haddad PM, Anderson IM. Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death. Drugs. 2002;62:1649-71.
24. Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004;24:62-9.
25. Camm AJ, Malik M, Yap YG. Risk of QT prolongation and torsades de pointes with psychotropic drugs. In: AJ Camm, M. Malik and YG Yap, Editors, Acquired long QT syndrome, Blackwell Futura, Oxford, pp. 2004;102-120.
26. Nielsen J, Graff C, Hardahl T, Andersen MP, Kristoffersen J, Struijk JJ, et al. Sertindole causes distinct electrocardiographic T-wave morphology changes. Eur Neuropsychopharmacol. 2009;19:702-7.
27. Algra A, Tijssen JG, Roelandt JR, Lubsen J. QT interval variables from 24 hour electrocardiograhy and the two year risk of sudden death. BR Heart J. 1993;70:43-8.
28. Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Archives of Internal Medicine. 2005;165:696-701.
29. Mehtonen OP, Aranko K, Malkonen L, Vapaatalo H. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand. 1991;84:56-64.
30. Drici MD, Wang WX, Liu X, Woosley RL, Flockhart DA. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. Journal of Clinical Psychopharmacology. 1998;18:477-81.
31. Vieweg WVR, Nicholson CS. Torsade de pointes ventricular tachycardia, QT interval, and psychotropic drugs. Medical Update for Psychiatrists. Oxford, England: Elsevier Sciences, Inc., 1997.